Key result
Daytime napping is linked to ~19% higher all-cause mortality, with excess risk for long naps.
Why the study?
Although napping is a prevalent worldwide habit and a suggested public health tool for sleep disorders, its association with the risk of cardiovascular disease and all-cause mortality remained unclear.
Does daytime napping increase the risk of cardiovascular disease and all-cause mortality compared to not napping?
Meta-Analysis (n=313,651)
Does daytime napping increase the risk of cardiovascular disease and all-cause mortality compared to not napping?
Answers are grounded in this paper and cite their sources.
Long daytime napping (>60 minutes/day) is associated with significantly increased risks of both cardiovascular disease and all-cause mortality, demonstrating a J-curve relationship between nap duration and cardiovascular risk.
Background Napping is a habit prevalent worldwide and occurs from an early age. Some sleep specialists have suggested it as a potential public health tool due to the prevalence of sleep disorder. However, the association between napping and the risk of cardiovascular disease (CVD) and all-cause mortality remains unclear. Purpose To assess the association between napping and the risk of CVD and all-cause mortality. Methods We conducted a systematic search of Medline, Embase and Cochrane databases from inception through December 2019 for prospective cohort studies investigating the association between napping and the risk of CVD and/or all-cause mortality. Overall estimates were calculated using random effect models with inverse variance weighting. Dose-response meta-analysis was performed using restricted cubic spline models. The results were reported as hazard ratio (HR) and 95% confidence interval (CI). Results A total of 313651 participants (57.8% female, 38.9% took naps) from 20 cohort studies were included in the analysis. Overall, pooled analysis detected no association between daytime nap and CVD (HR 1.13, 95% CI 0.99–1.28). However, in subgroup analysis including only participants who were female (HR 1.31, 95% CI 1.09–1.58), older (age>65 years) (HR 1.36, 95% CI 1.07–1.72), or took a longer nap (nap time>60 minutes) (HR 1.34, 95% CI 1.05–1.63), napping was significantly associated with a higher risk of CVD comparing to not napping. All-cause mortality was associated with napping overall (HR 1.19, 95% CI 1.12–1.26), and effect sizes were even more pronounced in females (HR 1.22, 95% CI 1.13–1.31), older participants (HR 1.27, 95% CI 1.11–1.45) and those who took a long nap (HR 1.30, 95% CI 1.12–1.47). Furthermore, after stratifying participants by night sleep time (<6 and >6h/day), no significant association was detected except those who slept >6h/day at night and took a long nap (HR 1.13, 95% CI 1.03–1.24). Dose-response analysis showed a J-curve relation between nap time and CVD (Figure 1). The HR decreased from 0 to 25 min/day, followed by a sharp increase in the risk at longer times. A positive linear relationship between nap time and all-cause mortality was also observed. Conclusion Long napping over 60 minutes per day is associated with increased risks of CVD and all-cause mortality. Night sleep duration may play a role in the relation between napping and all-cause mortality. Further, large-scale prospective cohort studies need to confirm our conclusion and investigate the underlying mechanisms driving these associations.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2020) conducted a meta-analysis in Cardiovascular disease and all-cause mortality risk (n=313,651). Daytime napping vs. Not napping was evaluated on Cardiovascular disease (CVD) and all-cause mortality (HR 1.19, 95% CI 1.12-1.26). Daytime napping was associated with higher all-cause mortality and higher CVD risk when naps exceeded 60 minutes.
Synapse has enriched 10 related papers. Consider them for comparative context: